Status:

COMPLETED

Prolongation of Progesterone Supplementation in Antagonist Cycles and Pregnancy Outcomes

Lead Sponsor:

Universitair Ziekenhuis Brussel

Conditions:

Infertility

Eligibility:

FEMALE

18-39 years

Phase:

PHASE1

PHASE2

Brief Summary

The objective of this study is to evaluate the effect of the prolongation of luteal support on the ongoing pregnancy rate (beyond 12 weeks of gestation )in recFSH/GnRH antagonist cycles.

Eligibility Criteria

Inclusion

  • Age equal or less than 39
  • Body mass index between 18-29 kg/m2
  • Presence of both ovaries
  • Basal hormonal values on day 2 of the cycle
  • Embryotransfer day3 or day5
  • 1 to 3 cycles

Exclusion

  • Endometriosis stage 3
  • Polycystic ovarian syndrome
  • Frozen or testicular sperm

Key Trial Info

Start Date :

September 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2010

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT01147770

Start Date

September 1 2008

End Date

June 1 2010

Last Update

July 3 2013

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Prolongation of Progesterone Supplementation in Antagonist Cycles and Pregnancy Outcomes | DecenTrialz